# STOCKHOLM 1.0
#=GF ID   SPARC_Ca_bdg
#=GF AC   PF10591.13
#=GF DE   Secreted protein acidic and rich in cysteine Ca binding region
#=GF AU   Finn RD;0000-0001-8626-2148
#=GF AU   Coggill P;0000-0001-5731-1588
#=GF SE   Pfam-B_3882 (release 22.0), PROSITE_PS00613
#=GF GA   22.00 22.00;
#=GF TC   22.00 22.00;
#=GF NC   21.90 21.90;
#=GF BM   hmmbuild HMM.ann SEED.ann
#=GF SM   hmmsearch -Z 75585367 -E 1000 --cpu 4 HMM pfamseq
#=GF TP   Domain
#=GF CL   CL0220
#=GF RN   [1]
#=GF RM   16121393
#=GF RT   The C-terminal Ca2+-binding domain of SPARC confers
#=GF RT   anti-spreading activity to human urothelial cells. 
#=GF RA   Delostrinos CF, Hudson AE, Feng WC, Kosman J, Bassuk JA; 
#=GF RL   J Cell Physiol. 2006;206:211-220.
#=GF DR   INTERPRO; IPR019577;
#=GF DR   SO; 0000417; polypeptide_domain;
#=GF CC   The SPARC_Ca_bdg domain of Secreted Protein Acidic and Rich in
#=GF CC   Cysteine is responsible for the anti-spreading activity of human
#=GF CC   urothelial cells. It is rich in alpha-helices. This
#=GF CC   extracellular calcium-binding domain contains two EF-hands that
#=GF CC   each coordinates one Ca2+ ion, forming a helix-loop-helix
#=GF CC   structure that not only drives the conformation of the protein
#=GF CC   but is also necessary for biological activity. The
#=GF CC   anti-spreading activity was dependent on the coordination of
#=GF CC   Ca2+ by a Glu residue at the Z position of EF-hand 2 [1].
#=GF SQ   18
#=GS A0MT19_STRPU/148-261  AC A0MT19.1
#=GS F6T3M2_CIOIN/213-351  AC F6T3M2.2
#=GS SPRC_CHICK/147-284    AC P36377.1
#=GS G3UR35_MELGA/523-661  AC G3UR35.2
#=GS G3V7X5_RAT/484-622    AC G3V7X5.2
#=GS A8Y2J4_CAEBR/138-252  AC A8Y2J4.1
#=GS B4GYW2_DROPE/165-277  AC B4GYW2.1
#=GS Q1HPY3_BOMMO/181-294  AC Q1HPY3.1
#=GS Q16II0_AEDAE/177-290  AC Q16II0.1
#=GS A7SG90_NEMVE/110-218  AC A7SG90.1
#=GS A7SPL6_NEMVE/109-215  AC A7SPL6.1
#=GS A7RFR0_NEMVE/170-293  AC A7RFR0.1
#=GS F7E3Y0_XENTR/191-300  AC F7E3Y0.2
#=GS TICN1_HUMAN/195-304   AC Q08629.1
#=GS H3C0L7_TETNG/119-229  AC H3C0L7.1
#=GS H2LN90_ORYLA/162-270  AC H2LN90.2
#=GS TICN3_PONAB/198-308   AC Q5RD69.2
#=GS H3CJ51_TETNG/116-225  AC H3CJ51.1
A0MT19_STRPU/148-261             MGSCSAEDLREYPERMTNWFIKSLALIRNRPEEH.........................GGLSQKEKETLQQEWSQSTHAIFWKFDRLDKNPSDHYLDFAELEGLRAPIVLFEPCTKPFLQACDVDNDTLISAVEFGRC
F6T3M2_CIOIN/213-351             IQPCGEHELSEYPTRMRSWIKNIYLQMYDEAEDMGGLNEKQRFHGRKLVANRDRLQTYEEHHIDLMSREFQKFYPLYKYPIHWKFGILDVNPTDKYLSKRELEPMRAPLVPLEHCTDTFFSTADANKDHLISLYEWAEA
SPRC_CHICK/147-284               IPACLDTELTEFPLRMRDWLKNVLITLYERDEDNNLLTEKQKLKVK.NIHENEKRLEAGDHTVELLARDFEKNYNMYIFPVHWQFGQLDQHPIDGYLSHTELAPLRAPLIPMEHCTTRFFEACDLDFDKYIALEEWASC
G3UR35_MELGA/523-661             IPHCTDYEVGQFPLRMRDWLKNILMQYYERDQDKPGFLTEKQRNKVKKIYLNEKRLVSGEHPVELLLHDFEKNYHMYVYPVHWQFYQLDQHPIDRSLTHSELAPLRASLVPMEHCITRFFQECDGDQDKLITLKEWCHC
G3V7X5_RAT/484-622               IPACTDFEVAQFPLRMRDWLKNILMQLYEPNPKHGGYLNEKQRSKVKKIYLDEKRLLAGDHPIELLLRDFKKNYHMYVYPVHWQFNELDQHPADRILTHSELAPLRASLVPMEHCITRFFEECDPNKDKHITLKEWGHC
A8Y2J4_CAEBR/138-252             LDECTEEHMAQFPERMADWLFQVMKELKKRRELH........................KLEWEELLSEAENDDEKKHVYPVIWKFCELDTKPHDKSVSHHELIPITAPVIPMESCIKPFLEGCDANNDGNISIKEWGKC
B4GYW2_DROPE/165-277             PRICDGEDLKEFPRRMRDWLFNVMRDLAERDELT.........................EHYMQMELEAETNNSRRWSNAAVWKWCDLDGD.TDRSVSRHELFPIRAPLVSLEHCIAPFLESCDSNNDHRITLIEWGAC
Q1HPY3_BOMMO/181-294             MPDCTESEMSDFPRRMRDWLFNIMRDMAERRELT.........................PHYLKMEREAESNLTRRWANAAIWKWCDLDAQTNDRFVSRHELFPIRAPLMALEHCIAPFLDRCDADDDHRVTLAEWGKC
Q16II0_AEDAE/177-290             MPDCSENDLADFPRRMRDWLFNVMRDLAVRNELP.........................EAYMELEQEAESNLTKRWTNAAIWKWCDLDGHPNDNSVSRHELFPIRAPLMTLEHCIAPFLETCDPNGDHRITLQEWGKC
A7SG90_NEMVE/110-218             VSECARDNLLQFGERYLEWILISRRRLVNRYYQV.............................KESEKGHNLPPDMRKELAQWEFDRVDFN.RDGVLSGREINSIIGPLLFHERCIYGFVMSCDVNKNSVIDKQEWLLC
A7SPL6_NEMVE/109-215             MTDCPKWMLEQFPYRFLDWLYLTRELSRDPRFEI...............................AKRGEQLTGDEIKEVLAWEFNNWDLN.KNGIWDKEELDLVQTILMPIEGCSFGFLKSCDLDGKGDMDRREWMMC
A7RFR0_NEMVE/170-293             QDNCTRFENATLGARLLDWFHVLRAEYIKTESRKAGHPVD............QPIFPKMDIREAHVPFPCGHSHQECREPINFMFHFLDKD.GDHVLGPEELAEVKE..IPNENCITQFFEKCDATKDGQFSLLEFCEC
F7E3Y0_XENTR/191-300             GETCTGQDLADLGDRLRDWFQLLHENSKQNNTSN..........................PGSKQVNVLDKSLVAGCKDSIGWMFSKLDSN.NDLFLDQAELAAINL..DKYEICIRPFFNSCDTYKDGRVSTAEWCFC
TICN1_HUMAN/195-304              RSACTDKELRNLASRLKDWFGALHEDANRVIKPT..........................SSNTAQGRFDTSILPICKDSLGWMFNKLDMN.YDLLLDPSEINAIYL..DKYEPCIKPLFNSCDSFKDGKLSNNEWCYC
H3C0L7_TETNG/119-229             RTGCTDSELHSLAARLKDWFRVLHLDANRDLKSS.........................DNFDSTTGHFDTSILPICKDSLGWMFNKLDIN.FDLLLDQSELSALYL..DKYEMCMKPLFNSCDSFKDGKLSNNEWCYC
H2LN90_ORYLA/162-270             KKVCSESELKEVVSRLRDWFRVLHENGNHKRVKI...........................QKPEKSKFEVGASPICKDPLGWMFSRLDTN.FDLQLDQSEIRSLYL..DRNEPCSDAFFRSCDTHPDKVITSSEWCTG
TICN3_PONAB/198-308              KRACSDLEFREVANRLRDWFKALHESGSQNKKTK.........................TLLRPERSRFDTSILPICKDSLGWMFNRLDTN.YDLLLDQSELRSIYL..DKNEQCTKAFFNSCDTYKDSLISNNEWCYC
H3CJ51_TETNG/116-225             RNSCTGQDLADLGDRLKDWFQLLHGNAKQNNSGR..........................PGSGTSSALDRSLGASCKDSIGWMFSKLDTD.SDLYLGQAELTAINL..DKYEICIRPFFNSCDTYKDGKISMAEWCLC
#=GC seq_cons                    hssCo-p-LtpaspRh+DWhtslhtphtccpppp..........................th.phtpcs-pp.hshhppsltWpFscLDts.tDthLsppELtslps.ls.hEpCIpsFFpoCDsspDppIohpEWstC
